Influence of bile acid derivates on morphine analgesic effect in mice

  • Velibor Vasović Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Saša Vukmirović Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Momir Mikov Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Ivan Mikov Department of Occupational Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Zorana Budakov Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Nebojša Stilinović Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Boris Milijašević Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
DOI: https://doi.org/10.2298/2711
Keywords: morphine, mice, bile acids and salts, blood-brain barrier,

Abstract



Background/Aim. It is known that bile acids improve the absorption, bioavailability and pharmacodynamic characteristics of some drugs. Morphine analgesia is produced by activation of opioid receptors within the central nervous system (CNS) at both spinal and supraspinal levels. Since a morphine molecule contains 3 polar groups and therefore hard to transfer through the blood-brain barrier, the aim of the study was to examine the potential influence of bile acids derivates, namely sodium salt of monoketocholic acid (MKH-Na) and methyl ester of monoketocholic acid (MKH-Me), on analgesic effect of morphine. Methods. White male mice of NMRI-Haan strain, with body weight of 20–24 g, were used in this study. The analgesic effect of morphine (administered by subcutaneous and intramuscular route in a dose of 2 mg/kg), with and without pretreatment with MKH-Na (4 mg/kg) and MKH-Me (4 mg/kg) was estimated by the hot plate method. Results. Administration of MKH-Me prior to subcutaneous administration of morphine increased the morphine analgesic effect but the increase was not statistically significant. At the same time administration of MKH-Na did not affect morphine analgesic effect. The analgesic effect of morphine increased when administered intramuscularly 20 min after MKH-Me administration. When compared with the group of animals treated only with morphine, a statistically significant increase in analgesic effect was detected 10, 30, 40 and 50 min after morphine administration (p < 0.05). Pretreatment with MKH-Na did not affect morphine analgesic effect. Conclusion. According to the results of this study it can be presumed that after intramuscular morphine administration methyl ester of monoketocholic acid increases morphine transport into the central nervous system and consequently the analgesic effect, as well. Further research on bile acids-morphine interaction both in vitro and in vivo is necessary to completely elucidate the mechanism of this interaction and increase in the morphine analgesic effect.

Author Biographies

Velibor Vasović, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, PhD, researcher

Saša Vukmirović, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, researcher

Momir Mikov, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, PhD, researcher

Ivan Mikov, Department of Occupational Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Occupational Medicine

MD, PhD, researcher

Zorana Budakov, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, researcher

Nebojša Stilinović, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, researcher

Boris Milijašević, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology

MD, researcher

References

Mikov M, Fawcett JP. Bile acids-chemistry, biosynthesis, analy-sis, chemical and metabolic transformation and pharmacology. 1st ed. Geneva: Mediset Publishers; 2008.

Al-Salami H, Butt G, Tucker I, Mikov M. Influence of the semi-synthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol Rep 2008; 60(4): 532−41

Hsiesh DS. Drug permeation enhancement: Theory and appli-cations. New York: Marcel Dekker; 1994.

Sayani AP, Chien YW. Systemic delivery of peptides and pro-teins across absorptive mucosae. Crit Rev Ther Drug 1996; 13(1−2): 85−184.

Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Lim-bird LE, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 569−619.

Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th. New York: Pergamon Press; 1990. p. 485−521.

Hoskin PJ, Hanks GW, Aherne GW, Chapman D, Littleton P, Fil-shie J. The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol 1989; 27(4): 499−505.

Berkowitz BA. The relationship of pharmacokinetics to phar-macological activity: morphine, methadone and naloxone. Clin Pharmacokinet 1976; 1(3): 219–30.

Institute of Laboratory Animal Research, Commission on Life Sciences. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington DC: National Academy Press; 1996.

Miljkovic D, Kuhajda K, Hranisavljevic J. Selective C-12 oxidation of cholic acid. J Chem Res 1996; 2: 106−7.

Mikov M, Kevresan S, Kuhajda K, Jakovljević V, Vasović V. 3Alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator. Pol J Pharmacol 2004; 56(3): 367−71.

Poša M, Kevrešan S, Mikov M, Ćirin-Novta V, Kuhajda K. Effect of cholic acid and its keto derivatives on the analgesic action of lidocaine and associated biochemical parameters in rats. Eur J Drug Metab Pharmacokinet 2007; 32(2): 109−17.

Vasovic V, Vukmirovic S, Pjevic M, Mikov I, Mikov M, Jakovljevic V. Influence of bile acid derivates on tramadol analgesic effect in mice. Eur J Drug Metab Pharmacokinet 2010; 35(1−2): 75−8.

Vogel G, Vogel WH. Drug discovery and evaluation: Pharma-cological assays. 2nd ed. Berlin: Springer-Verlag; 2002.

Rašković A, Mikov M, Škrbić R, Jakovljević V, Vasović V, Posa M, et al. Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats. Eur J Drug Metab Pharmacokinet 2008; 33(1): 17−22.

Posa M, Guzsvány V, Csanádi J, Kevresan S, Kuhajda K. Formation of hydrogen-bonded complexes between bile acids and lido-caine in the lidocaine transfer from an aqueous phase to chlo-roform. Eur J Pharm Sci 2008; 34(4−5): 281−92.

Vasovic V, Mikov M, Kuhajda K, Kevresan S, Jakovljevic V. The in-fluence of sodium salt of monoketocholic acid on quinine tran Yugoslav Physiol Pharmacol Acta 2001; 37(3): 89−98.

Poša M, Csanádi J, Kövér KE, Guzsvány V, Batta G. Molecular in-teractions between selected sodium salts of bile acids and morphine hydrochloride. Colloids Surf B Biointerfaces 2012; 94: 317−23.

Kuhajda I, Poša M, Jakovljević V, Ivetić V, Mikov M. Effect of 12-monoketocholic acid on modulation of analgesic action of morphine and tramadol. Eur J Drug Metab Pharmacokinet 2009; 34(2): 73−8.

Tsuji A, Terasaki T, Takabatake Y, Tenda Y, Tamai I, Yamashima T, et al. P-glycoprotein as the drug efflux pump in primary cul-tured bovine brain capillary endothelial cells. Life Sci 1992; 51(18): 1427−37.

Tatsuta T, Naito M, Oh-Hara T, Sugawara I, Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 1992; 267(28): 20383−91.

Callaghan R, Riordan JR. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem 1993; 268(21): 16059−64.

Schinkel AH, Wagenaar E, Van DL, Mol CA, Borst P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyc-losporin A. J Clin Invest 1995; 96(4): 1698−705.

Mazzanti R, Fantappié O, Kamimoto Y, Gatmaitan Z, Gentilini P, Arias IM. Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles. Hepatology 1994; 20(1 Pt 1): 170−6.

Lam P, Wang R, Ling V. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. Biochemistry 2005; 44(37): 12598−605.

Brunk SF, Delle M. Morphine metabolism in man. Clin Phar-macol Ther 1974; 16(1): 51−7.

Ronald AL, Docherty D, Broom J, Chambers WA. Subarachnoid local anesthetic block does not affect morphine absorption from paired intramuscular and subcutaneous injection sites in the elderly patient. Anesth Analg 1993; 76(4): 778−82.

Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML. Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 2000; 68(6): 667−76.

Skarke C, Darimont J, Schmidt H, Geisslinger G, Lötsch J. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther 2003; 73(1): 107−21.

Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sci 1987; 41(26): 2845−9.

Shimomura K, Kamata O, Ueki S, Ida S, Oguri K. Analgesic effect of morphine glucuronides. Tohoku J Exp Med 1971; 105(1): 45−52.

Gong QL, Hedner J, Björkman R, Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depres-sion in the rat. Pain 1992; 48(2): 249−55.

Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide: a po-tent antagonist of morphine analgesia. Life Sci 1990; 47(6): 579−85.

McEvoy GK. AHFS – Drug Information. 43rd ed. Bethesda, Md: American Society of Health-System Pharmacists, Inc; 2001.

Published
2015/04/23
Issue
Vol. 71 No. 8 (2014)
Section
Original Paper